HemoShear develops new medicines to improve the lives of patients with liver and metabolic diseases. They leverage proprietary human biological and computational systems to accelerate the discovery of innovative therapies that change the course of disease. HemoShear partners with biopharma companies to accelerate their drug discovery and development programs in liver diseases and gout.
